MindImmune is a startup focused on leveraging artificial intelligence to develop novel diagnostic tools for neurodegenerative diseases. Their approach aims to enable earlier and more accurate detection, potentially leading to improved patient outcomes and treatment strategies. The company emphasizes the use of advanced AI and machine learning techniques to analyze complex biological data.